LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10

Search options

  1. Article ; Online: Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.

    Ruiz-Aparicio, Paola Fernanda / Uribe, Gloria Inés / Linares-Ballesteros, Adriana / Vernot, Jean-Paul

    Molecules (Basel, Switzerland)

    2021  Volume 26, Issue 17

    Abstract: Cell adhesion to stromal support and the associated intracellular signaling are central to drug resistance, therefore blocking both has been effective in increasing drug sensitization in leukemia. The stromal Ser/Thr protein kinase C (PKC) has been found ...

    Abstract Cell adhesion to stromal support and the associated intracellular signaling are central to drug resistance, therefore blocking both has been effective in increasing drug sensitization in leukemia. The stromal Ser/Thr protein kinase C (PKC) has been found to be important for conferring protection to leukemic cells. We aimed at elucidating the intracellular signals connected to cell adhesion and to stromal PKC. We found that NF-κB and Akt were up-regulated in mesenchymal stem cells (MSC) after binding of B-cell acute lymphoblastic leukemia (B-ALL) cells. Nevertheless, Akt inhibition did not induce B-ALL cell detachment. In spite of a clear activation of the NF-κB signaling pathway after B-ALL cell binding (up-regulation NF-κB1/2, and down-regulation of the IKBε and IKBα inhibitors) and an important reduction in cell adhesion after NF-κB inhibition, sensitization to the drug treatment was not observed. This was opposite to the PKC inhibitors Enzastaurin and HKPS, a novel chimeric peptide inhibitor, that were able to increase sensitization to dexamethasone, methotrexate, and vincristine. PLCγ1, Erk1/2, and CREB appear to be related to PKC signaling and PKC effect on drug sensitization since they were contra-regulated by HKPS when compared to dexamethasone-treated cells. Additionally, PKC inhibition by HKPS, but not by Enzastaurin, in MSC reduced the activity of three ABC transporters in leukemic cells treated with dexamethasone, a new indirect mechanism to increase sensitization to drug treatment in B-ALL cells. Our results show the validity of targeting the functional characteristic acquired and modulated during cell-to-cell interactions occurring in the leukemic niche.
    MeSH term(s) ATP-Binding Cassette Transporters/antagonists & inhibitors ; ATP-Binding Cassette Transporters/metabolism ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Cell Adhesion/drug effects ; Drug Screening Assays, Antitumor ; Humans ; NF-kappa B/metabolism ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/metabolism ; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Precursor Cells, B-Lymphoid/drug effects ; Precursor Cells, B-Lymphoid/metabolism ; Precursor Cells, B-Lymphoid/pathology ; Protein Kinase C/antagonists & inhibitors ; Protein Kinase C/metabolism ; Protein Kinase Inhibitors/chemical synthesis ; Protein Kinase Inhibitors/chemistry ; Protein Kinase Inhibitors/pharmacology ; Tumor Cells, Cultured
    Chemical Substances ATP-Binding Cassette Transporters ; Antineoplastic Agents ; NF-kappa B ; Protein Kinase Inhibitors ; Protein Kinase C (EC 2.7.11.13)
    Language English
    Publishing date 2021-09-03
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules26175366
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia.

    Yunis, Luz K / Linares-Ballesteros, Adriana / Aponte, Nelson / Barros, Gisela / García, Johnny / Niño, Laura / Uribe, Gloria / Quintero, Edna / Yunis, Juan J

    Cancer reports (Hoboken, N.J.)

    2022  Volume 6, Issue 3, Page(s) e1744

    Abstract: Background and aim: Different studies have shown pharmacogenetic variants related to drug toxicity in acute myeloid leukemia (AML) patients. Our aim was to identify the association between ABCB1, CDA, DCK, GSTT1, and GSTM1 variants with clinical ... ...

    Abstract Background and aim: Different studies have shown pharmacogenetic variants related to drug toxicity in acute myeloid leukemia (AML) patients. Our aim was to identify the association between ABCB1, CDA, DCK, GSTT1, and GSTM1 variants with clinical outcomes and toxicity in pediatric patients with AML.
    Methods: Fifty-one confirmed de novo AML pediatric patients were included. A SNaPshot™ assay and conventional PCR were used to evaluate ABCB1, CDA, DCK, GSTT1, and GSTM1 variants. Clinical outcomes and toxicity associations were evaluated using odds ratios and Chi-square analysis.
    Results: Patients carrying ABCB1 (1236C > T, rs1128503) GG genotype in had a 6.8 OR (CI 95% 1.08-42.73, p = .044) for cardiotoxicity as compared to patients carrying either AA or GA genotypes 0.14 OR (CI 95% 0.023-0.92, p = .044). For ABCB1 (1236G > A rs1128503/2677C > A/T rs2032582/3435G > A rs1045642) AA/AA/AA combined genotypes had a strong association with death after HSTC OR 13.73 (CI 95% 1.94-97.17, p = .009). Combined genotypes GG/CC/GG with CDA (79A > C, rs2072671) CA genotype or CDA (-451G > A, rs532545) CT genotype, had a 4.11 OR (CI 95% 2.32-725, p = .007) and 3.8 OR (CI 95% 2.23-6.47, p = .027) with MRD >0.1% after first chemotherapy cycle, respectively.
    Conclusion: Our results highlight the importance of pharmacogenetic analysis in pediatric AML, particularly in populations with a high degree of admixture, and might be useful as a future tool for patient stratification for treatment.
    MeSH term(s) Humans ; Child ; Pharmacogenetics ; Colombia/epidemiology ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/genetics ; Genotype ; ATP Binding Cassette Transporter, Subfamily B/genetics ; ATP Binding Cassette Transporter, Subfamily B/therapeutic use
    Chemical Substances ABCB1 protein, human ; ATP Binding Cassette Transporter, Subfamily B
    Language English
    Publishing date 2022-10-31
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2573-8348
    ISSN (online) 2573-8348
    DOI 10.1002/cnr2.1744
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Leukemia-Induced Cellular Senescence and Stemness Alterations in Mesenchymal Stem Cells Are Reversible upon Withdrawal of B-Cell Acute Lymphoblastic Leukemia Cells.

    Vanegas, Natalia-Del Pilar / Ruiz-Aparicio, Paola Fernanda / Uribe, Gloria Inés / Linares-Ballesteros, Adriana / Vernot, Jean-Paul

    International journal of molecular sciences

    2021  Volume 22, Issue 15

    Abstract: Leukemic cell growth in the bone marrow (BM) induces a very stressful condition. Mesenchymal stem cells (MSC), a key component of this BM niche, are affected in several ways with unfavorable consequences on hematopoietic stem cells favoring leukemic ... ...

    Abstract Leukemic cell growth in the bone marrow (BM) induces a very stressful condition. Mesenchymal stem cells (MSC), a key component of this BM niche, are affected in several ways with unfavorable consequences on hematopoietic stem cells favoring leukemic cells. These alterations in MSC during B-cell acute lymphoblastic leukemia (B-ALL) have not been fully studied. In this work, we have compared the modifications that occur in an in vitro leukemic niche (LN) with those observed in MSC isolated from B-ALL patients. MSC in this LN niche showed features of a senescence process, i.e., altered morphology, increased senescence-associated β-Galactosidase (SA-βGAL) activity, and upregulation of p53 and p21 (without p16 expression), cell-cycle arrest, reduced clonogenicity, and some moderated changes in stemness properties. Importantly, almost all of these features were found in MSC isolated from B-ALL patients. These alterations rendered B-ALL cells susceptible to the chemotherapeutic agent dexamethasone. The senescent process seems to be transient since when leukemic cells are removed, normal MSC morphology is re-established, SA-βGAL expression is diminished, and MSC are capable of re-entering cell cycle. In addition, few cells showed low γH2AX phosphorylation that was reduced to basal levels upon cultivation. The reversibility of the senescent process in MSC must impinge important biological and clinical significance depending on cell interactions in the bone marrow at different stages of disease progression in B-ALL.
    MeSH term(s) Cell Differentiation ; Cell Proliferation ; Cells, Cultured ; Cellular Senescence ; Hematopoietic Stem Cells/pathology ; Humans ; Mesenchymal Stem Cells/pathology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Tumor Microenvironment
    Language English
    Publishing date 2021-07-29
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22158166
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Aprendizaje en las residencias quirúrgicas durante la pandemia de COVID-19 en México.

    Gómez-Herrera, María N / Cuéllar-Aguirre, Celina / Baridó-Murguía, María E / Sánchez-Montes, Irma / Barradas-Guevara, María C / González-Uribe, Gloria

    Cirugia y cirujanos

    2021  Volume 91, Issue 3, Page(s) 381–387

    Abstract: Objective: To bring up which was the surgical resident's perception about their learning experience during COVID-19 pandemic and if it interfered or not with their classes.: Method: Cross-sectional observational study through an anonymous survey ... ...

    Title translation Learning in surgical residences during the COVID-19 pandemic in Mexico.
    Abstract Objective: To bring up which was the surgical resident's perception about their learning experience during COVID-19 pandemic and if it interfered or not with their classes.
    Method: Cross-sectional observational study through an anonymous survey conducted among surgical residents. The Mexican Association of General Surgery, through its Women in Surgery Committee, created a questionnaire that included 40 questions.
    Results: 465 participants were included in the survey: 225 women (48.3%), 240 men (51.7%); of 32 entities, only 26 participated. A great part of them said their skills and abilities were affected because elective surgeries were called off. While 303 residents stayed at hybrid hospitals, while a third of them were at 100% Covid facilities. Residents who were on call worked at COVID-19 units. They continued attending class through online platforms and only 134 were able to practice their skills using simulators. 71% of the residents were infected with COVID-19, all were tested to confirm it, and the number of asymptomatic cases was unknown.
    Conclusions: COVID-19 pandemic has affected the learning process of surgical residents in Mexico.
    MeSH term(s) Male ; Humans ; Female ; COVID-19/epidemiology ; Cross-Sectional Studies ; Mexico/epidemiology ; Pandemics ; Elective Surgical Procedures
    Language English
    Publishing date 2021-04-06
    Publishing country Mexico
    Document type Observational Study ; Journal Article
    ZDB-ID 730699-4
    ISSN 2444-054X ; 0009-7411
    ISSN (online) 2444-054X
    ISSN 0009-7411
    DOI 10.24875/CIRU.22000294
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Genomic alterations in a cohort of pediatric acute myeloid leukemia patients at two cancer centers in Colombia.

    Yunis, Luz K / Linares-Ballesteros, Adriana / Barros, Gisela / Garcia, Johnny / Aponte, Nelson / Niño, Laura / Uribe, Gloria / Quintero, Edna / Perez, Jaime / Martinez, Leila / Yunis, Juan J

    International journal of hematology

    2022  Volume 117, Issue 2, Page(s) 269–277

    Abstract: Few studies identifying genomic aspects in pediatric acute myeloid leukemia patients in Latin American countries have been reported. The aim of this study was to identify genomic alterations, clinical characteristics and outcomes in a cohort of pediatric ...

    Abstract Few studies identifying genomic aspects in pediatric acute myeloid leukemia patients in Latin American countries have been reported. The aim of this study was to identify genomic alterations, clinical characteristics and outcomes in a cohort of pediatric AML patients. This descriptive observational cohort study included patients with confirmed de novo acute myeloid leukemia up to 18 years of age. Cytogenetics and conventional FISH analysis, next-generation sequencing and PCR testing were performed. The correlation of genomic data with treatment response and outcomes were analyzed. Of the 51 patients analyzed, 67.4% had a cytogenetic abnormality and 74.5% had a genetic variant. FLT3 variants (ITD or TKD D835) were found in 27.4%, followed by NRAS (21.6%), KRAS (13.7%) and WT1 and KIT (11.8%). Patients were stratified by risk (66.6% high-risk) after the end of induction. FLT3-ITD was associated with relapse (OR 11.25; CI 1.89-66.72, p 0.006) and NRAS with death during induction (OR 16.71; CI 1.51-184.59, p 0.022). Our study highlights the importance of rapid incorporation of genetic testing in pediatric AML in Colombia, as it directly affects treatment decisions and outcomes. Incorporation of targeted therapies with conventional chemotherapy is an increasingly urgent need in pediatric patients.
    MeSH term(s) Humans ; Colombia/epidemiology ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/drug therapy ; Chromosome Aberrations ; Recurrence ; Genomics ; Mutation ; Prognosis ; fms-Like Tyrosine Kinase 3/genetics
    Chemical Substances fms-Like Tyrosine Kinase 3 (EC 2.7.10.1)
    Language English
    Publishing date 2022-10-24
    Publishing country Japan
    Document type Observational Study ; Journal Article
    ZDB-ID 1076875-0
    ISSN 1865-3774 ; 0917-1258 ; 0925-5710
    ISSN (online) 1865-3774
    ISSN 0917-1258 ; 0925-5710
    DOI 10.1007/s12185-022-03475-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Philadelphia-like acute lymphoblastic leukemia: Characterization in a pediatric cohort in a referral center in Colombia.

    Linares Ballesteros, Adriana / Yunis, Luz Karime / García, Johnny / Aponte, Nelson / Flechas, Jessica / Martinez, Cindy / Uribe, Gloria / Quintero, Edna / Díaz, Angela / Pardo, Carlos / Sarmiento, Isabel Cristina / Contreras, Agustin / Yunis, Juan Jose

    Cancer reports (Hoboken, N.J.)

    2021  Volume 5, Issue 5, Page(s) e1587

    Abstract: Background: Philadelphia-like (Ph-like) acute lymphoblastic leukemia (ALL) is a subtype of pediatric leukemia with high risk factors and poor outcome. There are few reports of its prevalence in Latin America.: Aim: This study evaluated the frequency ... ...

    Abstract Background: Philadelphia-like (Ph-like) acute lymphoblastic leukemia (ALL) is a subtype of pediatric leukemia with high risk factors and poor outcome. There are few reports of its prevalence in Latin America.
    Aim: This study evaluated the frequency and clinical and biological characteristics of Ph-like ALL in a pediatric cancer center in Colombia.
    Methods: The Ph-like genetic profile was analyzed by a low-density array (LDA). Samples from patients with Ph-like ALL were analyzed by fluorescent in situ hybridization for cytokine receptor like factor 2 (CRLF2) and ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1) rearrangements. Copy number variations were assessed by multiplex ligation probe amplification.
    Results: Data from 121 patients were analyzed. Fifteen patients (12.4%) had Ph-like ALL, and these patients had significantly higher leukocyte counts at diagnosis and higher levels of minimal residual disease on days 15 and 33 of induction than patients without the Ph-like subtype. There were no significant differences in sex, age, or response to prednisone at day 8 between the two groups. CRLF2 rearrangements were identified in eight patients, and ABL1 rearrangements were identified in two patients. Other genetic alterations alone or in combination were identified in 77% of patients, including deletions in cyclin dependent kinase inhibitor 2 A/B (46.2%), IKAROS family zinc finger 1 (38.3%), and paired box 5 (30.8%).
    Conclusions: Ph-like ALL had a 12.4% prevalence in our cohort of patients with pediatric ALL. The identification of this group of patients has importance for risk stratification and future targeted therapy.
    MeSH term(s) Child ; Colombia/epidemiology ; DNA Copy Number Variations ; Humans ; Ikaros Transcription Factor/genetics ; In Situ Hybridization, Fluorescence ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/epidemiology ; Referral and Consultation
    Chemical Substances Ikaros Transcription Factor (148971-36-2)
    Language English
    Publishing date 2021-11-17
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2573-8348
    ISSN (online) 2573-8348
    DOI 10.1002/cnr2.1587
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Dual Targeting of Stromal Cell Support and Leukemic Cell Growth by a Peptidic PKC Inhibitor Shows Effectiveness against B-ALL.

    Ruiz-Aparicio, Paola Fernanda / Vanegas, Natalia-Del Pilar / Uribe, Gloria Inés / Ortiz-Montero, Paola / Cadavid-Cortés, Camila / Lagos, Jimmy / Flechas-Afanador, Jessica / Linares-Ballesteros, Adriana / Vernot, Jean-Paul

    International journal of molecular sciences

    2020  Volume 21, Issue 10

    Abstract: Mesenchymal stem cells (MSC) favour a scenario where leukemic cells survive. The protein kinase C (PKC) is essential to confer MSC support to leukemic cells and may be responsible for the intrinsic leukemic cell growth. Here we have evaluated the ... ...

    Abstract Mesenchymal stem cells (MSC) favour a scenario where leukemic cells survive. The protein kinase C (PKC) is essential to confer MSC support to leukemic cells and may be responsible for the intrinsic leukemic cell growth. Here we have evaluated the capacity of a chimeric peptide (HKPS), directed against classical PKC isoforms, to inhibit leukemic cell growth. HKPS was able to strongly inhibit viability of different leukemic cell lines, while control HK and PS peptides had no effect. Further testing showed that 30% of primary samples from paediatric B-cell acute lymphoblastic leukaemia (B-ALL) were also strongly affected by HKPS. We showed that HKPS disrupted the supportive effect of MSC that promote leukemic cell survival. Interestingly, ICAM-1 and VLA-5 expression increased in MSC during the co-cultures with B-ALL cells, and we found that HKPS inhibited the interaction between MSC and B-ALL cells due to a reduction in the expression of these adhesion molecules. Of note, the susceptibility of B-ALL cells to dexamethasone increased when MSC were treated with HKPS. These results show the relevance of these molecular interactions in the leukemic niche. The use of HKPS may be a new strategy to disrupt intercellular communications, increasing susceptibility to therapy, and at the same time, directly affecting the growth of PKC-dependent leukemic cells.
    MeSH term(s) Antineoplastic Agents/pharmacology ; B-Lymphocytes/drug effects ; B-Lymphocytes/metabolism ; Cell Adhesion ; Cell Proliferation ; Cells, Cultured ; Child ; Enzyme Inhibitors/pharmacology ; Humans ; Integrins/genetics ; Integrins/metabolism ; Intercellular Adhesion Molecule-1/genetics ; Intercellular Adhesion Molecule-1/metabolism ; Jurkat Cells ; K562 Cells ; Mesenchymal Stem Cells/drug effects ; Mesenchymal Stem Cells/metabolism ; Oligopeptides/pharmacology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/metabolism ; Protein Kinase C/antagonists & inhibitors ; Recombinant Proteins/pharmacology
    Chemical Substances Antineoplastic Agents ; Enzyme Inhibitors ; Integrins ; Oligopeptides ; Recombinant Proteins ; Intercellular Adhesion Molecule-1 (126547-89-5) ; Protein Kinase C (EC 2.7.11.13)
    Language English
    Publishing date 2020-05-25
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms21103705
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Factores explicativos de la aplicación de la Ley de autonomía del paciente por personal médico y de enfermería del área quirúrgica.

    Lopera Uribe, Gloria E / Albar Marín, M A Jesús / García Ramírez, Manuel / Fernández Garrido, Carmen

    Gaceta sanitaria

    2011  Volume 25, Issue 6, Page(s) 461–467

    Title translation Factors explaining the application of the law of patient autonomy by surgical staff.
    MeSH term(s) Confidentiality/legislation & jurisprudence ; Cooperative Behavior ; Cross-Sectional Studies ; General Surgery ; Guideline Adherence ; Informed Consent/legislation & jurisprudence ; Interprofessional Relations ; Models, Theoretical ; Nurses/psychology ; Patient Rights/legislation & jurisprudence ; Perioperative Nursing ; Personal Autonomy ; Physicians/psychology ; Professional Practice ; Regression Analysis ; Spain ; Surgery Department, Hospital/organization & administration ; Surveys and Questionnaires ; Truth Disclosure
    Language Spanish
    Publishing date 2011-11
    Publishing country Spain
    Document type English Abstract ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1038713-4
    ISSN 1578-1283 ; 0213-9111
    ISSN (online) 1578-1283
    ISSN 0213-9111
    DOI 10.1016/j.gaceta.2011.04.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Conocimiento de la ley de autonomía del paciente por el personal médico y de enfermería implicado en el proceso quirúrgico.

    Fernández-Garrido, Carmen / Lopera-Uribe, Gloria Elena / Méndez-Pérez, Laura / Otero-Espiga, Aída / Gallardo-Abril, María Gracia / Lagoa-Elías, Concepción

    Enfermeria clinica

    2009  Volume 19, Issue 6, Page(s) 330–334

    Abstract: Objective: To study the extent to which the Law of Patient Autonomy (LAP) is known by the medical and nursing staff of the surgical areas from the two university hospitals in Seville.: Methods: Cross sectional study, obtained in July 2008 from a ... ...

    Title translation Knowledge of the law of patient autonomy by medical and nursing staff involved in the surgical process.
    Abstract Objective: To study the extent to which the Law of Patient Autonomy (LAP) is known by the medical and nursing staff of the surgical areas from the two university hospitals in Seville.
    Methods: Cross sectional study, obtained in July 2008 from a survey prepared by Hospital Virgen Macarena (HVM) staff and reviewed by an expert (lawyer) from the Ministry of Health of the Autonomous Government of Andalusia. Sixty three out of one hundred professionals (doctors, nurses and nursing assistants) of the surgical area of the HVM and Virgen del Rocio (HVR) hospitals participated in the survey. We performed a frequency analysis of responses to the questions and applied the chi-square test to determine whether there were differences in knowledge depending on the hospital, professional status and sex.
    Results: Nearly seventy per cent of the participants (44) acknowledged to have made no attempt to learn the law, whereas only 14.3% (9) knew of some sort of hospital action to publicise the law. No significant difference in the knowledge of the law was found between the professionals of each hospital, while the level of knowledge was very modest in both places. However, we found a statistically significant difference in the personal initiative to learn about the LAP, depending on professional status, with the highest percentage being in nurses (P=0.05) and the lowest in doctors.
    Conclusions: For the implementation of the LAP in the hospitals, health personnel must have knowledge of it. This requires a commitment by hospitals directors and managers, as well as the people responsible for the different services.
    MeSH term(s) Cross-Sectional Studies ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Legislation as Topic ; Male ; Medical Staff, Hospital ; Nursing Staff, Hospital ; Personal Autonomy ; Surgery Department, Hospital ; Surveys and Questionnaires
    Language Spanish
    Publishing date 2009-11
    Publishing country Spain
    Document type English Abstract ; Journal Article ; Multicenter Study
    ISSN 1130-8621
    ISSN 1130-8621
    DOI 10.1016/j.enfcli.2009.07.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Correlación de la t(9;22), t(12;21) e hiperdiploidía de ADN con el inmunofenotipo y la tasa de proliferación de células B neoplásicas en niños con leucemia linfoblástica aguda de precursores.

    Quijano, Sandra Milena / Torres, María Mercedes / Vásquez, Liliana Edith / Cuéllar, Gina Elizabeth / Romero, Martha Liliana / Martín, Edna Liliana / Linares, Adriana / Castaño, Silverio / Sarmiento, Isabel Cristina / Cabrera, Edgar / Uribe, Gloria Inés / Andrade, Rafael Enrique / Saavedra, Carlos Eugenio

    Biomedica : revista del Instituto Nacional de Salud

    2013  Volume 33, Issue 3, Page(s) 468–486

    Abstract: Introduction: Between 60 and 80% of patients with B-cell acute lymphoblastic leukemia show genetic abnormalities which influence the prognosis of the disease and the biology of the tumor.: Objective: To analyze different genetic abnormalities in ... ...

    Title translation Correlation of the t(9;22), t(12;21), and DNA hyperdiploid content with immunophenotype and proliferative rate of leukemic B-cells of pediatric patients with B-cell acute lymphoblastic leukemia.
    Abstract Introduction: Between 60 and 80% of patients with B-cell acute lymphoblastic leukemia show genetic abnormalities which influence the prognosis of the disease and the biology of the tumor.
    Objective: To analyze different genetic abnormalities in acute B lymphoblastic leukemia in children, its relationship with the immunophenotype and the proliferative rate compared with normal B cell precursors.
    Materials and methods: We assessed immunophenotype, DNA content and proliferative rate in 44 samples by flow cytometry, and translocations t(9;22), t(12;21), t(4;11), and t(1;19) by RT-PCR. Using a hierarchical cluster analysis, we identified some immunophenotypic patterns associated to genetic abnormalities when compared with normal B cell precursors.
    Results: DNA quantification showed that 21% of the cases had high hyperdiploidy and 47.7% has low hyperdiploidy. The presence of hyperdiploidy was associated with increased tumor proliferation and aberrant immunophenotypes, including abnormal expression of CD10, TdT, CD38, and CD45 and an increased size of the lymphoblasts. The presence of t(9;22) and t(12;21) discriminates normal cells from tumor cells with aberrant immunophenotype in the expression of CD19, CD22, CD13, CD33, CD38, CD34, and CD45.
    Conclusions: The aberrant immunophenotype profile detected in neoplastic cells along with abnormalities in the proliferative rate were significantly associated with DNA hyperdiploidy and clearly distinguished lymphoblasts with t(9;22) and t(12;21) from normal B cell precursors. The identification of these parameters is useful as a tool for classification and monitoring of these patients.
    MeSH term(s) Adolescent ; B-Lymphocytes/classification ; Cell Proliferation ; Child ; Child, Preschool ; DNA, Neoplasm/analysis ; Diploidy ; Female ; Humans ; Immunophenotyping ; Infant ; Leukemia, B-Cell/genetics ; Leukemia, B-Cell/immunology ; Male ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology
    Chemical Substances DNA, Neoplasm
    Language Spanish
    Publishing date 2013-12-04
    Publishing country Colombia
    Document type English Abstract ; Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 0120-4157
    ISSN 0120-4157
    DOI 10.7705/biomedica.v33i3.1441
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top